Trial Profile
The immunogenicity of 7-valent pneumococcal conjugate vaccine (PCV-7) in allogeneic bone marrow transplant recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 08 Jun 2016 Status changed from recruiting to completed.
- 16 Aug 2011 New trial record